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Background: The WNT/β-CATENIN signaling cascade is crucial for the patterning of the early lung morphogenesis
in mice, but its role in the developing human lung remains to be determined. In this study, expression patterns of
canonical WNT/β-CATENIN signaling components, including WNT ligands (WNT2, WNT7B), receptors (FZD4, FZD7,
LRP5, LRP6), transducers (DVL2, DVL3, GSK-3β, β-CATENIN, APC, AXIN2), transcription factors (TCF4, LEF1) and
antagonists (SOSTDC1) were examined in human embryonic lung at 7, 12, 17 and 21 weeks of gestation (W) by
real-time qRT-PCR and in situ hybridization.
Results: qRT-PCR analysis showed that some of these components were gradually upregulated, while some were
significantly downregulated from the 7 W to the 12 W. However, most components reached a high level at 17 W,
with a subsequent decrease at 21 W. In situ hybridization showed that the canonical WNT ligands and receptors
were predominantly located in the peripheral epithelium, whereas the canonical WNT signal transducers and
transcription factors were not only detected in the respiratory epithelium, but some were also scattered at low
levels in the surrounding mesenchyme in the developing human lung. Furthermore, Western blot, qRT-PCR and
histological analysis demonstrated that the β-CATENIN-dependent WNT signaling in embryonic human lung was
activated in vitro by CHIR 99021 stimulation.
Conclusions: This study of the expression patterns and in vitro activity of the canonical WNT/β-CATENIN pathways
suggests that these components play an essential role in regulation of human lung development.
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The lung arises from a small diverticulum in the anterior
foregut endoderm at the laryngotracheal groove. The re-
spiratory epithelium then invades the surrounding mesen-
chyme, followed by the formation of respiratory
bronchioles and alveolar ducts [1,2]. Human lung mor-
phogenesis takes place at approximately four weeks of ges-
tation and continues into postnatal life up to early
adulthood. The events of growth and development of
human lung have traditionally been divided into five stages
according to changes in the structure of the airway tubes
and morphological modifications of epithelial cells: embry-
onic stage (0–7 weeks in utero), pseudoglandular stage* Correspondence: biozmf@163.com
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reproduction in any medium, provided the or(7–17 weeks in utero), canalicular stage (17–27 weeks in
utero), saccular stage (28–36 weeks in utero) and alveolar
stage (36 weeks in utero to 2 years of age) [3].
The process of lung development relies on the precise
coordination of epithelial -mesenchymal interactions
controlled by a number of complex signaling cascades,
including bone-morphogenic proteins (BMPs), fibroblast
growth factors (FGFs), sonic hedgehog (SHH) and the
wingless-type MMTV integration site family (WNT)
[1,4], which is known to regulate these interactions by
the means of autocrine and paracrine processes [5,6]. At
least three WNT signaling pathways are involved in
the signal transduction process, of which the canonical
WNT/β-CATENIN signaling pathway is the best char-
acterized [7]. In the unstimulated canonical WNT/
β-CATENIN pathway, β-CATENIN is bound to the
scaffold proteins axin and adenomatosis polyposis coli
(APC), constitutively phosphorylated by casein kinase I
and glycogen synthase kinase (GSK-3β) and subsequentlyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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WNT ligands to two distinct membrane receptors, the
frizzled (FZD) and low-density lipoprotein receptor-
related proteins (LRP) 5 and 6, leads to the phosphoryl-
ation of the cytoplasmic region of LPR6 by GSK-3β and
casein kinase-γ, which results in the recruitment of the
cytosolic proteins known as dishevelled (DVL) 1–3 and
axin. Subsequently, β-CATENIN is neither phosphory-
lated nor degraded, but accumulates in the cytoplasm,
where it translocates into the nucleus and regulates
expression of target genes such as cyclin D1, MMP7
and c-Myc through interactions with T cell-specific
transcription factor (TCF) and lymphoid enhancer-
binding factor (LEF) [7].
Many studies have used mouse genetic approaches to
show that canonical WNT signaling plays an important
role in the development of mammalian lung. For in-
stance, the WNT2 knockout mouse is associated with
perinatal lethality resulting from lung hypoplasia, which
is characterized by dilated endothelial vasculature,
decreased cell proliferation and downregulation of genes
crucial for normal lung development [8]. Mouse WNT2
and WNT2b double mutants exhibit under-development
of the lung including the absence of tracheal budding at
E9.5 (embryonic day 9.5) and lack of certain epithelial
cell markers (TTF-1 and p63) [8]. WNT7b knockout
mice die shortly after birth due to severe lung hypoplasia
with defects in branching morphogenesis and cell prolif-
eration, as well as defects in lung epithelial differenti-
ation. Smooth muscle α-actin expression is also
abnormal in WNT7b mutants [9]. Similarly, inactivation
of β-CATENIN in lung epithelium after lung budding
causes aberrant epithelial branching and proximal-distal
patterning [9,10]. Inactivation of β-CATENIN in lung
mesenchyme results in decreased mesenchymal growth
and defective endothelial differentiation [11]. Moreover,
the deletion of β-CATENIN during trachea/lung mor-
phogenesis results in shortening of the trachea and
reduced lung size [12].
It has also been reported that canonical WNT/
β-CATENIN signaling ligands (WNT2, WNT7B) [8,9,13],
receptors (FZD4, FZD7, LRP5, LRP6) [14,15], transducers
(DVL2, DVL3, GSK-3β, β-CATENIN, APC, AXIN2)
[16-19], as well as transcription factors (TCF4, LEF1)
[18,20] exhibit highly cell-specific expression patterns in
the developing murine lung. However, tissue-specific ex-
pression of certain components involved in the canonical
WNT/β-CATENIN signaling pathway during human
lung development has not yet been investigated. This
study demonstrated that canonical WNT signaling com-
ponents are expressed in specific spatio-temporal pat-
terns in the developing human lung by using real-time
qRT-PCR analysis and in situ hybridization. Analysis of
in vitro activity stimulated by CHIR 99021 furtherrevealed that the WNT/β-CATENIN signaling cascade
is crucial for early human lung patterning during
morphogenesis.
Results
Expression of canonical WNT/β-CATENIN signaling
component mRNA in the developing human lung
Human lung development can be divided into five stages
with distinct structures visible at each stage. The most
significant growth phase occurs in the pseudoglandular
stage (7–17 weeks in utero), followed by the canalicular
stage (17–27 weeks in utero). Therefore, as we previ-
ously described [21], the current study was focused on
events at 7 W, 12 W, 17 W and 21 W to analyze pat-
terns of gene expression in the developing human lung.
Quantification of the mRNA expression of canonical
WNT/β-CATENIN signaling components in human
lung tissues at 7 W, 12 W, 17 W and 21 W was per-
formed using real-time qRT-PCR. Investigation of the
transcription levels of the canonical WNT ligands,
WNT2 and WNT7B, revealed that WNT2 expression
decreased significantly from 7 W to 12 W with a subse-
quent gradual increase at 17 W and a further dramatic
decrease at 21 W (Figure 1A). In contrast, WNT7B tran-
scripts were markedly upregulated from 7 W to 12 W,
while a decreasing trend in WNT7B mRNA expression
was observed from 12 W to 21 W (Figure 1A).
Expression of canonical WNT receptors (FZD4,
FZD7) and co-receptors (LRP5, LRP6) was also
detected in human embryonic lung tissues. An obvious
increase in FZD4, LRP5 and LRP6 mRNA levels was
detected from 7 W to 17 W, whereas no changes in
FZD7 transcripts were observed during this period.
Interestingly, mRNA levels of four canonical WNT re-
ceptor genes (FZD4, FZD7, LRP5, LRP6) substantially
decreased from the 17 W to 21 W (Figure 1A and B).
Expression of canonical WNT signal transducers
(DVL2, DVL3, GSK-3β, β-CATENIN, APC, AXIN2) was
also determined by qRT-PCR in the developing human
lung. With exception of DVL3 and AXIN2, the mRNA
levels of DVL2, GSK-3β, β-CATENIN and APC were sig-
nificantly downregulated from 7 W to 12 W, while
DVL3 and AXIN2 expression markedly increased during
this period (Figure 1B and C). Subsequently, the expres-
sion of canonical WNT transducers (DVL2, DVL3, GSK-
3β, β-CATENIN, APC, AXIN2) increased at 17 W, but
decreased at 21 W (Figure 1B and C).
Finally, the mRNA expression levels of canonical
WNT signaling transcription factors (TCF4, LEF1) were
examined in human lung at 7 W, 12 W, 17 W and
21 W. TCF4 and LEF1 presented a similar expression
pattern in the developing human lung, with gradually
decreasing expression levels from 7 W to 12 W followed
by an obvious increase at 17 W and a further significant
A B
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Figure 1 Real-time qRT-PCR was performed to examine the mRNA expression levels (mean± sem) of canonical WNT/β-CATENIN
signaling components, including WNT ligands (WNT2, WNT7B), WNT receptors (FZD4, FZD7, LRP5, LRP6), WNT transducers (DVL2, DVL3,
GSK-3β, β-CATENIN, APC, AXIN2), WNT transcription factors (TCF4, LEF1) and WNT inhibitors or antagonists (SOSTDC1) in the developing
human lung at 7 W, 12 W, 17 W and 21 W (W: Weeks of gestation) (A-D). Data were normalized to the average mRNA level of β-actin at
7 W. Statistical difference is indicated by asterisks (*P< 0.05, **P< 0.01).
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the WNT signaling antagonist SOSTDC1 in embryonic
human lung tissues revealed that SOSTDC1 transcripts
were upregulated from 7 W to 12 W, steadily increased
to a high level at 17 W and subsequently declined at
21 W (Figure 1D).
In combination, these real-time qRT-PCR data
demonstrated that most canonical WNT/β-CATENIN
signaling components expressed in the developing
human lung and, with the exception of WNT7B and
FZD7, reached high levels at 17 W, subsequently de-
creasing at 21 W.
Expression pattern of canonical WNT/β-CATENIN signaling
components in the developing human lung
In situ hybridization was performed to confirm the ex-
pression patterns of canonical WNT/β-CATENIN sig-
naling components during human lung development at
7 W, 12 W, 17 W and 21 W. Initial H&E staining of
histological sections showed that, during the period from
7 W to 21 W (the pseudoglandular to the canalicular
stage), the airway and vascular networks continuously
branched and the airway epithelial cells differentiated
progressively from tall columnar cells, to short columnar
cells and then to cuboidal cells (Figure 2A–D). Thesedata indicate normal lung morphogenesis and are con-
sistent with our previous reports [21].
The mRNA expression patterns of canonical WNT
ligands (WNT2, WNT7B) were then examined in the
developing human lung by in situ hybridization. WNT2
expression was obviously restricted to epithelial cells of
the fetal lung at 7 W and 17 W but was dramatically
downregulated at 12 W and 21 W (Figure 2E–H).
WNT7B transcripts were clearly detected in the respira-
tory airways from 7 W to 17 W (Figure 2I–K) but were
barely detectable at 21 W (Figure 2L).Expression of canonical WNT signaling receptors in the
developing human lung
In situ hybridization was also used to determine the
expression patterns of canonical WNT/β-CATENIN sig-
naling receptors (FZD4, FZD7) and co-receptors (LRP5,
LRP6) in the developing human lung. FZD4, FZD7, LRP5
and LRP6, which exhibited very similar expression pat-
terns, were initially restricted to the conducting airways
and the peripheral epithelium from 7 W to 17 W
(Figure 3A–C, E–G, I–K and M–O). Expression was
subsequently maintained at a relatively low level in the
peripheral epithelium at 21 W (Figure 3D, H, L and P).
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Figure 2 Expression of canonical WNT/β-CATENIN signaling ligands in the developing human lung. (A-D) Morphogenesis of the early
human lung development at 7 W, 12 W, 17 W and 21 W (W: Weeks of gestation). WNT2 (E-H) and WNT7B (I-L) expression was detected in the
epithelium of human lungs at 7 W, 12 W, 17 W and 21 W. Scale bars = 100 μm in A-L.
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developing human lung
The mRNA expression pattern of canonical WNT/
β-CATENIN signal transducers DVL2, DVL3, GSK-3β, β-



















Figure 3 Expression of canonical WNT/β-CATENIN signaling receptors
signaling receptors, including FZD4 (A-D), FZD7 (E-H), LRP5 (I-L) and LRP6 (M
at 7 W, 12 W, 17 W and 21 W (W: Weeks of gestation). Scale bars = 100 μmlung by in situ hybridization. Expression of DVL2, GSK-
3β and APC was distinctively confined to the peripheral
epithelium from the pseudoglandular to the canalicular
stage (Figure 4A–D, I–L and Q–T), with the exception of





in the developing human lung. The expression of canonical WNT
-P), was clearly detected in the distal part of human lung epithelium
in A-P.
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mesenchyme at 7 W (Figure 4I). In contrast, three other
transducers, DVL3, β-CATENIN and AXIN2, were
expressed strongly in the peripheral epithelium and
weakly throughout the mesenchyme surrounding the ter-
minal buds from the pseudoglandular to the canalicular
stage (Figure 4E–H, M–P and U–X).
The strength of the signals attained by in situ
hybridization showed that DVL2, DVL3 and AXIN2 ex-
pression remained relatively high from 7 W to 17 W
(Figure 4A–C, E–G and U–W) and was obviously downre-
gulated at 21 W (Figure 4D, H and X). Interestingly, the


































Figure 4 Expression of canonical WNT/β-CATENIN transducers in the
gestational ages of 7 W, 12 W, 17 W and 21 W (W: Weeks of gestation) sho
DVL2 (A-D), GSK-3β (I-L) and APC (Q-T) in the distal epithelium. However, th
(also β-CATENIN, M-P) and AXIN2 (U-X) was detected mainly in the distal ep
lungs at the gestational age of 7 W, 12 W, 17 and 21 W. Scale bars = 100 μappeared strong at 7 W and 17 W (Figure 4I, K, M, O, Q
and S), but were dramatically reduced and almost un-
detectable at 12 W and 21 W (Figure 4J, L, N, P, R and T).
Expression of canonical WNT signaling transcription
factors in the developing human lung
The distribution of canonical WNT/β-CATENIN signal-
ing transcription factors (TCF4, LEF1) was examined
during human lung development by in situ hybridization.
TCF4 was highly expressed in the peripheral epithelium
and in small amounts in the surrounding mesenchymal
cells during the pseudoglandular stage (Figure 5A–C),







developing human lung. Sections of the human embryos at the
wed particular expression of canonical WNT signal transducers
e expression of WNT signal transducers DVL3 (E-H), CTNNB1
ithelium and also weakly in the mesenchyme of human embryonic
m in A-X.
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Subsequently, TCF4 and LEF1 expression was downregu-
lated significantly in both the peripheral epithelium and
the mesenchyme at the canalicular stage (Figure 5D–
H). Furthermore, expression of WNT signaling inhibi-
tor or antagonist SOSTDC1 was also detected by in
situ hybridization. Positive SOSTDC1 staining was pre-
dominantly localized in the peripheral epithelium dur-
ing the pseudoglandular stage (Figure 5I–K) and
persisted into the canalicular stage (Figure 5L). Nega-
tive controls for in situ hybridization in the developing
human lung were shown in Figure 5M–P.
All the in situ hybridization data obtained in this
study showed that expression of canonical WNT/
β-CATENIN signaling components was mainly loca-
lized in the bronchial and alveolar epithelium in em-
bryonic human lung tissues, although some of the
components were found to be expressed at low levels
in the surrounding mesenchyme. Moreover, the expres-
sion patterns of canonical WNT/β-CATENIN signaling
components detected by in situ hybridization were

























Figure 5 Expression of canonical WNT/β-CATENIN signaling transcript
canonical WNT signaling transcription factor TCF4 was detected in both the
7 W, 12 W, 17 W and 21 W (W: week of gestation). (E-H) LEF1 staining of in
of the lung at 7 W, 12 W, 17 W and 21 W in human embryos. (I-L) Sections
distal lung epithelium of the embryos at 7 W, 12 W, 17 W and 21 W (W: w
developing human lung. Scale bars = 100 μm in A-P.Activity of canonical WNT/β-CATENIN signals in the
developing human lung
To further assess canonical WNT signaling activities in
the developing human lung, CHIR 99021 was used to
activate WNT/β-CATENIN signaling cascades [22]
through in vitro exposure of human lung explants
(15 W) to 0, 5 and 10 μM CHIR 99021 for 72 h. As pre-
sented in Figure 6A and B, Western blot analysis showed
β-CATENIN expression in 15 W human lung explants
decreased significantly from newly isolated to in vitro
cultured for 72 h (0 μM). However, β-CATENIN expres-
sion nearly increased back to newly isolated levels in
human lung explants at 15 W treated with 5 μM CHIR
99021 for 72 h, but decreased again after treatment of
10 μM CHIR 99021. Meanwhile, qRT-PCR analyses
showed increased expression of transcription factors
(LEF1, TCF4) and target genes (CYCLIN D1, MMP7) in
human lung explants (15 W) exposed to 5 μM CHIR
99021 compared with tissues exposed to 0 μM CHIR
99021, the levels of which were also higher than in the
10 μM CHIR 99021 groups (Figure 6C).
We then performed histological analysis. The human





ion factors in the developing human lung. (A-D) Expression of
distal epithelium and the lung mesenchyme of human embryos at
situ hybridization showed a strong reactivity in the distal epithelium
with SOSTDC1 staining showed particular expression patterns in the
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Figure 6 Activity of canonical WNT/β-CATENIN signals induced by CHIR 99021 in the developing human lung. Human lung tissue
explants obtained at 15 weeks of gestation were exposed to 0, 5 and 10 μM CHIR 99021 in vitro for 72 h. (A-B) Western blot analysis showed
expression of β-CATENIN in human lung tissues. Results are presented as the mean± sem of three independent experiments. *P< 0.05, **P< 0.01.
(C) qRT-PCR analysis detected a dose-dependent increase in WNT signaling transcription factors and target genes following exposure to CHIR
99021. Results are presented as the mean± sem of three independent experiments. *P< 0.05, **P< 0.01. (D-K) Histology examination showed
obvious morphogenetic changes of the airway epithelial cells associated with CHIR 99021 treated lung tubes. Scale bars: D-G =100 μm;
H-K= 20 μm.
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thelial cells around the tubes from short columnar to cu-
boidal morphology (Figure 6D–E and H–I). However,
parallel explant tissues treated with 5 μM CHIR 99021
for 72 h differentiated back to short columnar cells
(Figure 6F and J), with slighter changes between cu-
boidal and short columnar shape observed in the groups
exposed to 5 μM CHIR 99021 (Figure 6G and K). In
contrast, no obvious differences were observed in the
amount of lung tubes formed in the control and CHIR
99021 treated explant tissues.
Discussion
Crucial roles of canonical WNT/β-CATENIN signaling
components in the developing human lung
This study described the mRNA expression of canonical
WNT/β-CATENIN signaling components at the tissue
level during human lung development at 7 W, 12 W,17 W and 21 W. Most of the canonical WNT signaling
components were detected at 7 W and increased to high
levels at 17 W followed by a decrease at 21 W using
quantitative real-time qRT-PCR. Expression of all essen-
tial components was demonstrated in the fetal lung and
shown to be predominantly localized to the respiratory
and peripheral epithelium by in situ hybridization.
Human lung development can be divided into five
stages [3]. At around 4 weeks of gestation, the lung
develops as an outgrowth from the ventral wall of the
foregut, with trachea subsequently branching into the
lobar and segmental bronchi. At approximately 7 weeks
of gestation, the airways further branched and epithelial
cells differentiated progressively into tall pseudostratified
columnar epithelium. By 12 weeks, many small tubular
structures surrounded by short columnar cells were dis-
tributed throughout the human lung sections. From
17 weeks of gestation, the short columnar epithelium
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proximal direction. At 21 weeks of gestation, the differ-
entiation of pneumocytes and some extent of alveoliza-
tion could be observed in human lung [3,21]. All in all,
in human lung, 70 % of the total airways generated at
birth are formed by 14 W [23] and all of the conducting
airways and terminal bronchioles are formed by the end
of 17 W [24]. Therefore, it was speculated that most of
the canonical WNT signaling components were already
present in the lung buds, but their functions may be pre-
dominantly involved in branching and division of con-
duction airway or terminal bronchioles during the
pseudoglandular stage (7–17 weeks in utero). This hy-
pothesis is also supported by previous reports that the
WNT signaling system is not necessary for the establish-
ment of the primary branching pattern of the lung but is
required for appropriate branching morphogenesis [25].
Analysis of gene expression patterns indicated that all
of the canonical WNT/β-CATENIN signaling compo-
nents were mainly expressed in the peripheral epithe-
lium, although the canonical WNT signal transducers
and transcription factors were also slightly scattered into
the surrounding mesenchyme in the developing human
lung. Correct patterning of lung tissues depends on
epithelial-mesenchymal cell interactions [6]. Therefore,
it is possible that the canonical WNT signals are primar-
ily transduced into the epithelial cells through WNT
receptors and co-receptors and then activated by down-
stream signal transducers and transcription factors both
in the peripheral epithelium and mesenchymal cells
through epithelial-mesenchymal cell interactions. It is
also possible that the fast and progressive differentiation
of tubular structures and epithelial cells during human
lung development results in the slighter and weaker
strength of signals in the mesenchyme attained by in situ
hybridization, consistent with our previous observations
[21].
CHIR 99021 is one of a new class of highly selective
GSK-3 inhibitors that effectively inhibit GSK-3 activity
under many conditions in isolated cells and tissues [26].
In this study, CHIR99021 was used to activate canonical
WNT/β-CATENIN signaling components in the devel-
oping human lung. Increased expression of β-CATENIN
and WNT signal transcription factors (TCF4, LEF1) and
target genes (CYCD1, MMP7) was observed in human
lung tissues (15 W) after exposure to CHIR 99021.
Königshoff et al. also demonstrated increased mRNA
levels of the WNT target gene CYCD1 in response to
WNT signal activation by WNT3A in human lung tis-
sues in vitro [27]. Furthermore, additional activities of
WNT signaling in human lung tissues (15 W) stimulated
by CHIR 99021 did not accelerate the branching and
division of airway conduction, but activated the airway
epithelial cells retarding back from cuboidal to shortcolumnar cells, which was contrary to the normal lung
morphogenesis that the airway epithelial cells differen-
tiated progressively from tall columnar cells, to short
columnar cells and then to cuboidal cells [21].
Wnt/β-catenin signaling is one of the critical develop-
mental pathways that are considered important for both
self-renewal and differentiation of stem/progenitor cells
[28]. During lung epithelial regeneration, the Wnt sig-
naling controls the balance between stem/progenitor ex-
pansion and epithelial differentiation. Forced activation
of canonical Wnt signaling leads to increased bronch-
ioalveolar stem cell (BASCs) expression and decreased
epithelial differentiation [29]. Wnt signaling has also
been implicated in specifying early lung endoderm pro-
genitors. Activation of Wnt/β-catenin signaling can re-
program posterior endoderm to a lung progenitor fate
[8]. Moreover, β-catenin maintained airway epithelial
progenitor cells in relatively undifferentiated state, and
stabilization of β-catenin in Clara cell blocked postnatal
secretory cell maturation and secretory-to-ciliated cell
differentiation [28]. Therefore, in our studies, it is pos-
sible that these additional WNT signaling activities re-
program the airway epithelial cells in human embryonic
lung to the early epithelial cells, which indicated the
roles of WNT signaling pathway not only in appropriate
lung branching morphogenesis, but also in lung cell fate
decisions and differentiation. Furthermore, a WNT sig-
naling feedback mechanism may exist in human lung tis-
sues for expression of β-CATENIN, WNT signaling
transcription factors and target genes, and differentiation
of airway epithelial cells all decreased in the presence of
relatively high CHIR 99021 concentrations.
Comparison of canonical WNT/β-CATENIN signaling
expression patterns in embryonic mouse and human lung
WNT signaling is known to regulate murine lung speci-
fication and development by appropriate spatial and
temporal mechanisms [5]. Several WNT ligands, recep-
tors and components of the canonical pathway are
widely expressed in the developing murine lung. For in-
stance, WNT2 is highly expressed in the developing lung
mesenchyme [8], while WNT7b is predominantly loca-
lized in distal and proximal bronchial epithelial cells
[9,13]. In addition, a wide range of WNT receptors in-
cluding FZD4, FZD7, LRP5, and LRP6 are expressed in
tissue-specific patterns during murine lung development.
FZD4 and FZD7 are expressed primarily in the develop-
ing lung mesenchyme, whereas LRP5 and LRP6 are
expressed in the airway epithelium of lung tissues
[14,15]. In this study, expression of WNT2, WNT7B,
FZD4, FZD7, LRP5 and LRP6 in the developing human
lung was distinctly restricted to the alveolar and bron-
chial epithelium. This pattern of expression differs from
that found in mouse lung.
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WNT ligands to the FZD receptors complex with LRP,
leading to increased levels of cytosolic β-CATENIN and
resulting in the translocation of β-CATENIN into the
nucleus and regulation of target gene expression through
interaction with the transcription factors, TCF and LEF
[7]. In the mouse, three DVL genes (DVL1, 2, 3) are
widely, but not specifically, expressed in embryonic tis-
sues [30]. DVL2 and DVL3 are expressed at relatively
high and moderate levels respectively in lung tissues, al-
though DVL1 expression has not been determined [19].
β-CATENIN is localized in the cytoplasm and the nu-
cleus of the epithelium and adjacent mesenchyme in the
developing mouse lung [18]. However, GSK-3β, APC
and Axin2 exhibit moderate or weak expression levels,
but are not specified in E14.5 mouse lung tissues [17]. In
this study, other WNT signal transducers (DVL3, β-
CATENEN and AXIN2) were shown to be present not
only in the peripheral epithelium, but also at low levels
in the sub-adjacent mesenchyme during human lung de-
velopment, whereas DVL2 and APC were localized in
the lung epithelium only.
Similar to the expression pattern of β-CATENIN, TCF
and LEF1 were expressed in both adjacent mesenchyme
and the proximal epithelium of the embryonic mouse
lung [18,20]. However, in the developing human lung it
was observed that LEF1 was restricted to the alveolar and
bronchial epithelium, while TCF4 was expressed both in
the epithelium and the mesenchyme. Taken together,
these results suggest that, although the basic mechanism
governing establishment of functional and structural di-
versity within the respiratory system is likely to be con-
served among mammals [31], the canonical WNT
signaling pathway components exhibit some different ex-
pression patterns in developing human and mouse lungs.
The clinical significance of the canonical WNT signaling
pathway in human lung development
In addition to its role in lung development and morpho-
genesis, the canonical WNT signaling pathway is also
linked to the pathogenesis of human lung diseases, such
as lung cancer, lung fibrosis, lung inflammation, pulmon-
ary arterial hypertension (PAH) and bronchopulmonary
dysplasia (BPD) [32]. The role of WNT signaling in vari-
ous types of cancer is well established. For example, dif-
ferential expression of several WNT components
including WNT1, WNT2, WNT7A, DVL3, β-CATENIN
and APC, have been reported in normal lung tissues and
lung cancers, particularly in NSCLC (non-small cell lung
cancer) [33-36]. Studies in animal models, as well as in
human disease, have identified several components of the
canonical WNT signaling pathway, including WNT2,
FZD7, LRP6, β-CATENIN and GSK-3β which are over-
expressed in idiopathic pulmonary fibrosis (IPF) [27]. Incontrast, the role of WNT signaling in lung inflammation
is largely unexplored, although the canonical pathway ac-
tivator WNT-1 is implicated in lung inflammation by
being linked to stimulation of pro-MMP3 transcription
[37]. PAH characterized by cellular and structural
changes in pulmonary arteries, has also been shown to
be associated with mutations in BMPRII via activation of
the WNT signaling pathway [38]. Furthermore, gene ex-
pression analysis of pulmonary arterial resistance vessels
demonstrated differential regulation of canonical and
non-canonical WNT genes in PAH [39]. BPD is a chronic
lung disease in infants characterized by lung injury
resulting from mechanical ventilation and oxygen expos-
ure or from defects in lung development. A role for
WNT signaling in BPD is suggested by activation of the
pathway during hyperoxia-induced neonatal rat lung in-
jury [40]. Dysregulation of the canonical WNT signaling
pathway leads to lung disease and therefore, this investi-
gation of the canonical WNT/β-CATENIN pathway in
humans provides both further elucidation of the patho-
genesis of WNT-related human lung disease and identifi-
cation of potential therapeutic targets. Furthermore,
given the ability of canonical Wnt signaling to regulate
stem cell/progenitor expansion and regeneration in the
lung, the future to use agonists of this pathway to in-
crease lung injury repair and regeneration may be
possible.
Conclusions
This study is the first to describe the expression patterns
of the canonical WNT signaling components in the
developing human lung. Real-time qRT-PCR data
demonstrated most of components were detected at 7 W
and increased to high levels at 17 W followed by a de-
crease at 21 W. All the in situ hybridization data showed
that expression of canonical WNT signaling components
was mainly localized in the bronchial and alveolar epithe-
lium in embryonic human lung tissues, although some of
the components were expressed at low levels in the sur-
rounding mesenchyme. The canonical WNT signaling
activity was stimulated by in vitro exposure of human
lung tissues into CHIR 99021. Our data of the specific
spatio-temporal patterns and in vitro activity of canonical
WNT signaling in the developing human lung revealed
that the WNT/β-CATENIN signaling cascade is crucial
for early human lung patterning during morphogenesis.
Methods
Tissue preparations
Human embryos at 7 to 21 weeks gestation (7 W-21 W)
were obtained from the Hospital for Women and Children
of Fujian Province after legal termination of pregnancy.
The use of human embryos in this study was approved by
the Ethical Committee of Fujian Normal University. All
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http://www.biomedcentral.com/1471-213X/12/21donors gave written informed consent for the use of their
tissues for scientific purposes. Embryos were washed in
phosphate buffered saline (PBS) and the lungs were dis-
sected and fixed by overnight immersion in 4 % parafor-
maldehyde (PFA) in PBS at 4 °C. The specimens were
then dehydrated in a graded ethanol series and embedded
in paraffin. Sections (thickness, 6 μm) were prepared and
subjected to hematoxylin and eosin (H&E) staining and in
situ hybridization.
RNA isolation and real-time qRT-PCR
Total RNA was extracted from 50-100 mg human em-
bryonic tissues with TRIzol (Invitrogen, CA, USA)Table 1 Primer sequences and amplicon sizes for real-time PC
Gene Accession Seque
WNT2 NM_003391 For CTGAC
Rev AGGA
WNT7B NM_058238 For GTCAG
Rev TCTGG
FZD4 NM_012193 For TACCT
Rev GGCTG
FZD7 NM_003507 For GCAA
Rev AACC
LRP5 NM_002335 For ATGG
Rev AGATG
LRP6 NM_002336 For TTGTT
Rev CGTTT
DVL2 NM_004422 For TGAG
Rev GCAG
DVL3 NM_004423 For ACAA
Rev AGCTC
GSK-3β NM_002093 For TCGAG
Rev CGGA
CTNNB1 NM_001904 For TCTGA
(β-CATENIN) Rev TGGG
APC NM_001127511 For CATGA
Rev GCTGT
AXIN2 NM_004655 For GAGT
Rev GGTG
TCF4 NM_001083962 For CTGCC
Rev TGCCA
LEF1 NM_016269 For AATGA
Rev GCTGT
SOSTDC1 NM_015464 For CTTGC
Rev CTCGT
β-ACTIN NM_001101 For CATGT
Rev CTCCTaccording to the instructions provided by the manufac-
turer. Template cDNAs were obtained by reverse tran-
scription of total RNAs using oligo (dT) primer and
superscript II reverse transcriptase (TAKARA, Japan).
Amplification was carried out using SYBR Green qPCR
Master Mix (TAKARA). Sequences of the real-time
qRT-PCR primers used are listed in Table 1.
Quantitative real-time qRT-PCR was performed using
an ABI System Sequence Detector 7300 (Applied Biosys-
tems, Foster City, CA, USA) under the following ther-
mocycler conditions: stage 1, 95 °C for 30s, 1 cycle; stage
2: 95 °C for 5 s and 60 °C for 31 s, 40 cycles. β-actin was
used as an internal control for the expression levels ofR
nces (5’! 3’) Length Amplicon
CTGATGCAGACGCAAG 21 bp 139 bp
GCCACCTGTAGCTCTCATGTA 25 bp
GGATGTTTGTCCCACTTG 23 bp 69 bp
TAGGTCCTTGTGCCACTC 23 bp
CACAAAACCCCCATCC 21 bp 132 bp
TATAAGCCAGCATCAT 21 bp
AGCAGCGCAAATCTGA 20 bp 116 bp
TCTGGCTTAACGGTGTGTG 23 bp
GCGCCAGAACATCAA 19 bp 117 bp
TCGATGCTGAGGTCGTG 22 bp
GCTTTATGCAAACAGACG 23 bp 167 bp
AATGGCTTCTTCGCTGAC 23 bp
CAACGATGACGCTGTG 20 bp 148 bp
GGTCAATTGGCTGGA 19 bp
TGCCAAGCTACCATGCTTC 23 bp 109 bp
CGATGGGTTATCAGCAC 22 bp
AGCTCCAGATCATGAGAA 23 bp 124 bp
ACATAGTCCAGCACCAGA 22 bp
GGACAAGCCACAAGATTACA 25 bp 122 bp
CACCAATATCAAGTCCAA 22 bp
TGCTGAGCGGCAGA 19 bp 104 bp
TTCATGGTCCATTCGTG 22 bp
GGACTTGTGCCGACTTCA 22 bp 189 bp
GCTGGTGCAAAGACATAG 22 bp
TTAGGGACGGACAAAG 21 bp 101 bp
AAGAAGTTGGTCCATTTT 23 bp
GAGCGAATGTCGTTGC 21 bp 137 bp
CTTTCTTTCCGTGCTA 21 bp
CCCTGCCAGTGCTCC 20 bp 211 bp
TGTGCTGCCGGGTGT 20 bp
ACGTTGCTATCCAGGC 21 bp 250 bp
TAATGTCACGCACGAT 21 bp
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terms of the average cycle number of PCR amplification
(CT value) for the target gene where Δ=CT (target gene
sample) - CT (β-actin sample). Furthermore, ΔΔ=Δ
(target gene value for samples at 12 W, 17 W and 21 W)
- Δ (target gene value for the sample at 7 W). Finally,
the formula: 2-ΔΔ was used to calculate the amount of
RNA relative to the control.In situ hybridization
In situ hybridization was performed as previously
described [41]. The human cDNA vectors for WNT2,
WNT7B, FZD7, LRP6, DVL2, DLV3, GSK-3β, APC, AXIN2
and TCF4 digoxygenin-labelled probes were amplified
from cDNA templates, which were synthesized from total
RNA derived from human lung at 17 W. Sequences of the
PCR primers and the enzyme sites used for insertion into
the pBluescriptII KS plasmid are shown in Table 2. Other
digoxygenin-labelled RNA probes for in situ hybridization
of lung sections were generated from the following tem-
plates: FZD4, LRP5 and LEF1 plasmids (kind gifts from
Dr. Yiping Chen of Tulane University, USA), CTNNB1
and SOSTDC1 plasmids (Open Biosystems, USA). Tissue
sections hybridized with sense probes were used as nega-
tive controls.Table 2 Primer sequences and amplicon sizes for PCR and in
Gene Accession Sequences (5’! 3
WNT2 NM_003391 For CCGCTCGAGTGGG
Rev TGCTCTAGA TTAG
WNT7B NM_058238 For CCGCTCGAGCCCG
Rev TGCTCTAGACAGCC
FZD7 NM_003507 For CCGCTCGAGCCTCC
Rev TGCTCTAGACAACC
LRP6 NM_002336 For CCGCTCGAGGTGG
Rev TGCTCTAGACCACC
DVL2 NM_004422 For CCGCTCGAGGGGC
Rev TGCTCTAGAGCAGC
DVL3 NM_004423 For CCGCTCGAGGGCA
Rev TGCTCTAGATGCTC
GSK-3β NM_002093 For CCGCTCGAGGGAC
Rev TGCTCTAGAGCTCA
APC NM_001127511 For CCGCTCGAGCGCG
Rev TGCTCTAGATTGCC
AXIN2 NM_004655 For CCGCTCGAGGCCC
Rev TGCTCTAGACGCAA
TCF4 NM_001083962 For CCGCTCGAGGCTCG
Rev TGCTCTAGATGCACPseudoglandular explant cultures and CHIR 99021
treatment
Pseudoglandular explant cultures were prepared as previ-
ously described [42]. Briefly, fetal human lungs (15 W)
were isolated from surrounding structures, cut into cubes
(0.5-1 mm3) and divided into four groups. One group
was dehydrated in a graded ethanol series and embedded
in paraffin. The remaining three groups were cultured on
an air-liquid interface using permeable supports (Trans-
well, 0.4-μm pore size; Corning, USA) in DMEM media
in the absence or presence of CHIR 99021 (5 and
10 μM). Explants were cultured at 37 °C in 95 % air/5 %
CO2 for up to 72 h prior to collection for analyses. A
stock solution of CHIR 99021 (S1263, Selleck Chemicals,
USA) was prepared at 1 mM and stored at 4 °C.Western blotting
Protein extracts of human lung explants (15 W) before
or after CHIR 99021 treatment for 72 h were prepared
according to a previously described nuclear protein ex-
traction protocol [43]. Extracts were subjected to West-
ern blot analysis using mouse anti-human β-CATENIN
(1:1000, Millipore, USA) and mouse anti-human β-actin
(1:500, Zhongshan Goldenbridge Biotechnology Co.,
Ltd., China) primary antibodies. Blots incubated in thesitu hybridization
’) Enzyme sites Amplicon
AACAGTAAAGAAAGCAGAAT XhoI 608 bp
CTCTGGAAACCTCTCTGTCA XbaI
GGGTGGCAGTAGGTAGC XhoI 664 bp
ATCCCCCTCTCCGGTAC XbaI
TGCGGTGTGCTTGTC XhoI 519 bp
AACGGGAAACCTCAGA XbaI
AAGGGAATAATGGAAGC XhoI 698 bp
AGATCAAGATGCACATTTA XbaI
GCTCCTGGTGTGTGAC XhoI 434 bp
TACATGGCCCAAATCTCC XbaI
CGCTCACTCCCTCATTCT XhoI 464 bp
CAGGCCCAGGGTAAAT XbaI
TCCTGCCTCATGCCCCT XhoI 527 bp
GCCTGCTCAACACCCC XbaI
CTTACTGTGAAACCTGTT XhoI 723 bp
TGTGGTCCTCATTTGTAG XbaI
GAAGCTCTTGTGAACTGTCT XhoI 650 bp
CATGGTCAACCCTCAAGA XbaI
GCTGCCCTAGTAACAA XhoI 678 bp
ACTACTTCGGCTACACAG XbaI
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http://www.biomedcentral.com/1471-213X/12/21absence of the primary antibodies were used as negative
controls. The Polink-2 plus Polymer HRP Detection Sys-
tem for mouse primary antibodies (Zhongshan Golden-
bridge Biotechnology Co., Ltd.) was used as the
secondary antibody. Western Blotting Chemilumins-
cence Luminol Reagent (Santa Cruz, USA) was added to
detect immunopositive protein bands. The data was
obtained from triplicates of each independent experiment.
Values were normalized to corresponding β-ACTIN levels
and then expressed as a percentage of the control value.
Statistical analysis
Experimental data were presented as mean ± standard
error of the mean (sem) from at least three independent
experiment. The data were analyzed with ANOVA ac-
companied by Student’s t-test to detect significant differ-
ences of two independent groups by using the SigmaPlot
10.0 Software. Differences with P < 0.05 or P < 0.01 were
considered to be statistically significant.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
The authors declare the following contributions: conceived the study and
design of experiments: MFZ. Collected tissues: MFZ and JPS. Performed the
experiments and analysis: MFZ, JPS and YDH. Manuscript preparation and
discussion: MFZ and LJL. All authors read and approved the final manuscript.
Acknowledgments
We thank Dr. Yi-Ping Chen (Tulane University, USA) for kindly providing us
some plasmids. We also thank our laboratory members for their technical
assistance and constructive discussions. This work was supported by grants
from the National Natural Science Foundation of China (No. 31000643).
Author details
1Fujian Key Laboratory of Developmental Biology and Neurobiology, College
of Life Sciences, Fujian Normal University, Qishan Campus, Fuzhou 350108,
People's Republic of China. 2Department of Allied Health Sciences, University
of Connecticut, Storrs, CT 06269, USA.
Received: 26 March 2012 Accepted: 19 July 2012
Published: 30 July 2012
References
1. Cardoso WV, Lu J: Regulation of early lung morphogenesis: Questions,
facts and controversies. Development 2006, 133(9):1611–1624.
2. Warburton D, Bellusci S, De Langhe S, Del Moral PM, Fleury V, Mailleux A,
Tefft D, Unbekandt M, Wang K, Shi W: Molecular mechanisms of early lung
specification and branching morphogenesis. Pediatr Res 2005,
57(5 Pt 2):26R–37R.
3. Joshi S, Kotecha S: Lung growth and development. Early Hum Dev 2007,
83(12):789–794.
4. Whitsett JA, Clark JC, Picard L, Tichelaar JW, Wert SE, Itoh N, Perl AK,
Stahlman MT: Fibroblast growth factor 18 in Xuences proximal
programming during lung morphogenesis. J Biol Chem 2002,
277(25):22743–22749.
5. Okubo T, Hogan BL: Hyperactive Wnt signaling changes the
developmental potential of embryonic lung endoderm. J Biol 2004,
3(3):11.
6. Shannon JM, Hyatt BA: Epithelial–mesenchymal interactions in the
developing lung. Annu Rev Physiol 2004, 66:625–645.
7. Königshoff M, Eickelberg O: WNT signaling in lung disease: a failure or a
regeneration signal? Am J Respir Cell Mol Biol 2010, 42(1):21–31.8. Goss AM, Tian Y, Tsukiyama T, Cohen ED, Zhou D, Lu MM, Yamaguchi TP,
Morrisey EE: Wnt2/2b and β-catenin signaling are necessary and
sufficient to specify lung progenitors in the foregut. Dev Cell 2009,
17(2):290–298.
9. Shu W, Jiang YQ, Lu MM, Morrisey EE: Wnt7b regulates mesenchymal
proliferation and vascular development in the lung. Development 2002,
129(20):4831–4842.
10. Mucenski ML, Wert SE, Nation JM, Loudy DE, Huelsken J, Birchmeier W,
Morrisey EE, Whitsett JA: beta-CATENIN is required for specification of
proximal/distal cell fate during lung morphogenesis. J Biol Chem 2003,
278(41):40231–40238.
11. De Langhe SP, Carraro G, Tefft D, Li C, Xu X, Chai Y, Minoo P, Hajihosseini
MK, Drouin J, Kaartinen V: Formation and differentiation of multiple
mesenchymal lineages during lung development are regulated by
β-catenin signaling. PLoS One 2008, 3(1):e1516.
12. Li Y, Gordon J, Manley NR, Litingtung Y, Chiang C: Bmp4 is required for
tracheal formation: A novel mouse model for tracheal agenesis. Dev Biol
2008, 322(1):145–155.
13. Weidenfeld J, Shu W, Zhang L, Millar SE, Morrisey EE: The WNT7b promoter
is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. J Biol Chem
2002, 277(23):21061–21070.
14. Schulte G: International Union of Basic and Clinical Pharmacology. LXXX.
The class Frizzled receptors. Pharmacol Rev 2010, 62(4):632–667.
15. Wang Z, Shu W, Lu MM, Morrisey EE: Wnt7b activates canonical signaling
in epithelial and vascular smooth muscle cells through interactions with
Fzd1, Fzd10, and LRP5. Mol Cell Biol 2005, 25(12):5022–5030.
16. Aoki K, Taketo MM: Adenomatous polyposis coli (APC): a multi-functional
tumor suppressor gene. J Cell Sci 2007, 120(Pt 19):3327–3335.
17. Diez-Roux G, Banfi S, Sultan M, Geffers L, Anand S, Rozado D, Magen A,
Canidio E, Pagani M, Peluso I: A high-resolution anatomical atlas of the
transcriptome in the mouse embryo. PLoS Biol 2011,
9(1):e1000582.
18. Tebar M, Destrée O, de Vree WJ, Ten Have-Opbroek AA: Expression of
Tcf/Lef and sFrp and localization of β-catenin in the developing mouse
lung. Mech Dev 2001, 109(2):437–440.
19. Tsang M, Lijam N, Yang Y, Beier DR, Wynshaw-Boris A, Sussman DJ: Isolation
and characterization of mouse dishevelled-3. Dev Dyn 1996,
207(3):253–262.
20. Oosterwegel M, van de Wetering M, Timmerman J, Kruisbeek A, Destree O,
Meijlink F, Clevers H: Differential expression of the HMG box factors TCF-1
and LEF-1 during murine embryogenesis. Development 1993,
118(2):439–448.
21. Zhang M, Wang H, Teng H, Shi J, Zhang Y: Expression of SHH signaling
pathway components in the developing human lung. Histochemistry and
Cell Biology 2010, 134(4):327–335.
22. Tighe A, Ray-Sinha A, Staples OD, Taylor SS: GSK-3 inhibitors induce
chromosome instability. BMC Cell Biol 2007, 8:34.
23. Jeffery PK: The development of large and small airways. Am J Respir Crit
Care Med 1998, 157(5 Pt 2):S174–S180.
24. Kotecha S: Lung growth for beginners. Paediatr Respir Rev 2000,
1(4):308–313.
25. De Langhe SP, Reynolds SD: Wnt signaling in lung organogenesis.
Organogenesis 2008, 4(2):100–108.
26. Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST,
Reeder JW, Samuels I, Slabiak T: Selective glycogen synthase kinase 3
inhibitors potentiate insulin activation of glucose transport and
utilization in vitro and in vivo. Diabetes 2003, 52(3):588–595.
27. Königshoff M, Balsara N, Pfaff EM, Kramer M, Chrobak I, Seeger W, Eickelberg
O: Functional Wnt signaling is increased in idiopathic pulmonary fibrosis.
PLoS One 2008, 3(5):e2142.
28. Reynolds SD, Zemke AC, Giangreco A, BL B, Teisanu RM, Drake JA, Mariani T,
Di PY, Taketo MM, Stripp BR: Conditional stabilization of β-catenin
expands the pool of lung stem cells. Stem Cells 2008, 26(5):1337–1346.
29. Zhang Y, Goss AM, Cohen ED, Kadzik R, Lepore JJ, Muthukumaraswamy K,
Yang J, DeMayo FJ, Whitsett JA, Parmacek MS: A gata6-wnt pathway
required for epithelial stem cell development and airway regeneration.
Nature Gen 2008, 40(7):862–870.
30. Hamblet NS, Lijam N, Ruiz-Lozano P, Wang J, Yang Y, Luo Z, Mei L, Chien
KR, Sussman DJ, Wynshaw-Boris A: Dishevelled 2 is essential for cardiac
outflow tract development, somite segmentation and neural tube
closure. Development 2002, 129(24):5827–5838.
Zhang et al. BMC Developmental Biology 2012, 12:21 Page 13 of 13
http://www.biomedcentral.com/1471-213X/12/2131. Chuang PT, McMahon AP: Branching morphogenesis of the lung: new
molecular insights into an old problem. Trends Cell Biol 2003, 13(2):86–91.
32. Pongracz JE, Stockley RA: Wnt signaling in lung development and
diseases. Respir Res 2006, 7:15.
33. Chen S, Guttridge DC, You Z, Zhang Z, Fribley A, Mayo MW, Kitajewski J,
Wang CY: Wnt-1 signaling inhibits apoptosis by activating β-catenin/T
cell factor-mediated transcription. J Cell Biol 2001, 152(1):87–96.
34. He B, You L, Uematsu K, Xu Z, Lee AY, Matsangou M, McCormick F, Jablons
DM: A monoclonal antibody against wnt-1 induces apoptosis in human
cancer cells. Neoplasia 2004, 6(1):7–14.
35. Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM: Activation of the
wnt pathway in non-small cell lung cancer: Evidence of dishevelled
overexpression. Oncogene 2003, 22(46):7218–7221.
36. You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I, Reguart N, Moody TW,
Kitajewski J, McCormick F: Inhibition of wnt-2-mediated signaling induces
programmed cell death in non-small-cell lung cancer cells. Oncogene
2004, 23(36):6170–6174.
37. Warner RL, Bhagavathula N, Nerusu KC, Lateef H, Younkin E, Johnson KJ,
Varani J: Matrix metalloproteinases in acute inflammation: induction of
MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure
to pro-inflammatory mediators in vitro. Exp Mol Pathol 2004,
76(3):189–195.
38. de Jesus Perez VA, Alastalo TP, Wu JC, Axelrod JD, Cooke JP, Amieva M,
Rabinovitch M: Bone morphogenetic protein 2 induces pulmonary
angiogenesis via wnt-β-catenin and wnt-rhoa-rac1 pathways. J Cell Biol
2009, 184(1):83–99.
39. Laumanns IP, Fink L, Wilhelm J, Wolff JC, Mitnacht-Kraus R, Graef-Hoechst S,
Stein MM, Bohle RM, Klepetko W, Hoda MA, Schermuly RT, Grimminger F,
Seeger W, Voswinckel R: The non-canonical wnt-pathway is operative in
idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol 2009,
40(6):683–691.
40. Dasgupta C, Sakurai R, Wang Y, Guo P, Ambalavanan N, Torday JS, Rehan
VK: Hyperoxia-induced neonatal rat lung injury involves activation of
TGF-β and Wnt signaling and is protected by rosiglitazone. Am J Physiol
Lung Cell Mol Physiol 2009, 296(6):L1031–L1041.
41. Zhang Y, Zhao X, Hu Y, St Amand T, Zhang M, Ramamurthy R, Qiu M, Chen
Y: Msx1 is required for the induction of Patched by Sonic hedgehog in
the mammalian tooth germ. Dev Dyn 1999, 215(1):45–53.
42. Prince LS, Okoh VO, Moninger TO, Matalon S: Lipopolysaccharide increases
alveolar type II cell number in fetal mouse lungs through Toll-like
receptor 4 and NFkappaB. Am J Physiol Lung Cell Mol Physiol 2004,
287(5):L999–L1006.
43. Chilov D, Hofer T, Bauer C, Wenger RH, Gassmann M: Hypoxia affects
expression of circadian genes PER1 and CLOCK in mouse brain. FASEB J
2001, 15(14):2613–2622.
doi:10.1186/1471-213X-12-21
Cite this article as: Zhang et al.: Expression of canonical WNT/β-CATENIN
signaling components in the developing human lung. BMC
Developmental Biology 2012 12:21.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
